Cargando…
Predicting selective drug targets in cancer through metabolic networks
The interest in studying metabolic alterations in cancer and their potential role as novel targets for therapy has been rejuvenated in recent years. Here, we report the development of the first genome-scale network model of cancer metabolism, validated by correctly identifying genes essential for ce...
Autores principales: | Folger, Ori, Jerby, Livnat, Frezza, Christian, Gottlieb, Eyal, Ruppin, Eytan, Shlomi, Tomer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Molecular Biology Organization
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159974/ https://www.ncbi.nlm.nih.gov/pubmed/21694718 http://dx.doi.org/10.1038/msb.2011.35 |
Ejemplares similares
-
Predicting selective drug targets in cancer through metabolic networks
por: Folger, Ori, et al.
Publicado: (2011) -
Predicting selective drug targets in cancer through metabolic networks
por: Folger, Ori, et al.
Publicado: (2011) -
Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism
por: Jerby, Livnat, et al.
Publicado: (2010) -
Flux balance analysis accounting for metabolite dilution
por: Benyamini, Tomer, et al.
Publicado: (2010) -
Genome-Scale Metabolic Modeling Elucidates the Role of Proliferative Adaptation in Causing the Warburg Effect
por: Shlomi, Tomer, et al.
Publicado: (2011)